Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding study of lercanidipine + enalapril combinations in essential hypertension
2009-015988-13Phase 2Completed
- Sponsor
- Recordati SpA
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lercanidipine and enalapril in essential hypertension (9 arms), sponsored by Recordati SpA. Primary endpoint: Change from baseline in mean office seated diastolic blood pressure at trough after 10 weeks. Started Nov 2009; status: completed.
02
Drugs
lercanidipineenalapril
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2009-015988-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015988-13.